Psychology - OPEN Foundation

3,4-Methylenedioxymethamphetamineassisted psychotherapy for treatment of chronic posttraumatic stress disorder: A randomized phase 2 controlled trial

Ot’alora G, M., Grigsby, J., Poulter, B., Van Derveer III, J. W., Giron, S. G., Jerome, L., ... & Mithoefer, M. C. | Journal of Psychopharmacology | 29 October 2019

Esketamine Prevents Treatment-Resistant Depression Relapse.

Slomski, A. | Jama | 22 October 2019

The ethics of psychedelic research in disorders of consciousness.

Peterson, A., Tagliazucchi, E., & Weijer, C. | Neuroscience of Consciousness | 9 October 2019

Acute effects of lysergic acid diethylamide (LSD) on resting brain function.

Müller, F., & Borgwardt, S. | Swiss Medical Weekly | 30 September 2019

The psychedelic renaissance: the next trip for psychiatry?

Kelly, J. R., Baker, A., Babiker, M., Burke, L., Brennan, C., & O’Keane, V. | Irish journal of psychological medicine | 23 September 2019

Self-Rated Effectiveness of Microdosing With Psychedelics for Mental and Physical Health Problems Among Microdosers

Hutten, N. R., Mason, N. L., Dolder, P. C., & Kuypers, K. P. | Frontiers in psychiatry | 13 September 2019

Exploring ayahuasca‐assisted therapy for addiction: A qualitative analysis of preliminary findings among an Indigenous community in Canada

Argento, E., Capler, R., Thomas, G., Lucas, P., & Tupper, K. W. | Drug and alcohol review | 5 September 2019

Hallucinogens and Their Therapeutic Use: A Literature Review

BEGOLA, M. J., & SCHILLERSTROM, J. E. | Journal of Psychiatric Practice | September 2019

Psychedelic drugs-a new era in  psychiatry? 

Garcia-Romeu, A., & Richards, W. A. | International Review of Psychiatry | September 2019

Repeated ketamine injections in synergy with antidepressants for treating refractory depression: A case showing 6-month improvement.

Wang, M., Xiong, Z., Su, B., Wang, L., Li, Z., Yang, Y., & Fang, J. | Journal of clinical pharmacy and therapeutics | 30 August 2019

Attenuation of antidepressant and antisuicidal effects of ketamine by opioid receptor antagonism.

Williams, N. R., Heifets, B. D., Bentzley, B. S., Blasey, C., Sudheimer, K. D., Hawkins, J., ... & Schatzberg, A. F. | Molecular psychiatry | 29 August 2019

MDMA-assisted psychotherapy for posttraumatic stress disorder: A promising novel approach to treatment.

Vermetten, E., & Yehuda, R. | Neuropsychopharmacology | 27 August 2019

Efficacy of 3,4-methylenedioxymethamphetamine (MDMA)-assisted psychotherapy for posttraumatic stress disorder: A systematic review and meta-analysis.

Bahji, A., Forsyth, A., Groll, D., & Hawken, E. R. | Progress in Neuro-Psychopharmacology and Biological Psychiatry | 19 August 2019

Psilocybin-assisted mindfulness training modulates self-consciousness and brain default mode network connectivity with lasting effects

Smigielski, L., Scheidegger, M., Kometer, M., & Vollenweider, F. X. | NeuroImage | 1 August 2019

Promises and concerns regarding the use of ketamine and esketamine in the treatment of depression.

Pérez‐Esparza, R., Kobayashi‐Romero, L. F., García‐Mendoza, A. M., Lamas‐Aguilar, R. M., & Fonseca‐Perezamador, A. | Acta Psychiatrica Scandinavica | August 2019

Classical psychedelics for the treatment of depression and anxiety: A systematic review.

Muttoni, S., Ardissino, M., & John, C. | Journal of affective disorders | 30 July 2019

Metabolism of lysergic acid diethylamide (LSD): an update.

Libânio Osório Marta, R. F. | Drug metabolism reviews | 16 July 2019

Esketamine for treatment resistant depression.

Swainson, J., Thomas, R. K., Archer, S., Chrenek, C., MacKay, M. A., Baker, G., ... & Demas, M. L. | Expert Review of Neurotherapeutics | 16 July 2019

Effects of the synthetic psychedelic 2,5-dimethoxy-4-iodoamphetamine (DOI) on ethanol consumption and place conditioning in male mice.

Oppong-Damoah, A., Curry, K. E., Blough, B. E., Rice, K. C., & Murnane, K. S. | Psychopharmacology | 15 July 2019

First study of safety and tolerability of 3,4-methylenedioxymethamphetamine (MDMA)-assisted psychotherapy in patients with alcohol use disorder: preliminary data on the first four participants

Sessa, B., Sakal, C., O’Brien, S., & Nutt, D. | BMJ Case Reports CP | 15 July 2019